Leukapheresis Market worth $100 million by 2028
The Global Leukapheresis Products Market was estimated to be worth USD 70 million in 2023 and is poised to reach USD 100 million by 2028, growing at a CAGR of 8.3%. The global leukopaks market was estimated to be worth USD 200 million in 2023 and is poised to reach USD 1020 million by 2028, growing at a CAGR of 38.1%. One of the key trends in the leukopaks market is the increasing use of leukopaks in CAR T-cell therapy. CAR T-cell therapy is a type of immunotherapy that uses the patient's own immune cells to fight cancer. It is a promising new treatment for leukemia and other blood cancers. Leukopaks are used to collect the patient's immune cells, which are then modified to fight cancer. Other trends in the leukopaks market include the increasing demand for leukopaks in personalized medicine and the development of new leukopak collection and storage methods. Attractive Opportunities in the Leukapheresis Products Market Download PDF Brochure: https://www.marketsandma...